April 27 (Reuters) – AbbVie (ABBV.N) on Thursday underperformed its quarterly sales estimates for its new therapeutics as …
Tag:
AbbVie
-
-
AbbVie Inc. (NYSE: ABBV) provided a regulatory update on new drug applications (NDAs). ABBV-951 Wednesday Morning. Things to …